Growth Metrics

Medpace Holdings (MEDP) Change in Accured Expenses (2016 - 2026)

Medpace Holdings has reported Change in Accured Expenses over the past 12 years, most recently at -$1.3 million for Q1 2026.

  • Quarterly Change in Accured Expenses rose 94.39% to -$1.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $118.9 million through Mar 2026, up 700.75% year-over-year, with the annual reading at $97.1 million for FY2025, 475.07% up from the prior year.
  • Change in Accured Expenses was -$1.3 million for Q1 2026 at Medpace Holdings, down from $39.6 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $45.3 million in Q3 2025 and troughed at -$23.2 million in Q1 2025.
  • The 5-year median for Change in Accured Expenses is $19.3 million (2022), against an average of $14.5 million.
  • Biggest five-year swings in Change in Accured Expenses: plummeted 156.48% in 2023 and later soared 1241.54% in 2025.
  • Tracing MEDP's Change in Accured Expenses over 5 years: stood at $4.6 million in 2022, then skyrocketed by 486.8% to $27.2 million in 2023, then tumbled by 89.14% to $2.9 million in 2024, then soared by 1241.54% to $39.6 million in 2025, then tumbled by 103.29% to -$1.3 million in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods came in at -$1.3 million, $39.6 million, and $45.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.